Our Company
Key Facts
Leadership
Governance
History
Compliance & Ethics
Diversity & Inclusion
Our Websites
Achievements
Business Information
R&D
R&D Strategy
In the Pipeline
Disease Areas of Focus
Our R&D
Our Science
R&D Highlights
Major R&D Facilities
Clinical Trials
Products
Patient Assistance Programs
Prescribing Information
R&D
Clinical Trials
Counterfeit Drugs
News
Press Releases
Publications
Media Library
Key Facts
Leadership
Financial Reporting
Features
Achievements
Media Contacts
Subscribe to e-mail alerts
Investors
Key Facts
Stock Information
SEC Filings
Financial Reporting
Events & Presentations
Shareholder Services
Investor Contacts
Partnering
Why Partner With Us?
Areas of Interest
Our Process
Our Partners
Partnering News
Partnering Contact
Responsibility
Bristol-Myers Squibb Foundation
Sustainability
Patient Assistance Programs
Building Our Communities
Grants & Giving
Position on Key Issues
Clinical Trials
Combating Counterfeit Drugs
Achievements
Careers
Job Opportunities
Our Culture
Diversity & Inclusion
Developing Our People
University Recruitment
Achievements
Benefits
Manage My Profile
Apply Now
SITE INDEX
|
CONTACT US
|
TERMS
|
PRIVACY
Health Care Professionals
Access
medical information and resources
Clinical Trials
Bristol-Myers Squibb-sponsored
clinical trials
Need Help Paying for Your Bristol-Myers Squibb Medicines?
Learn about our
assistance programs
.
August 20, 2009
Derivative Action Settlement Notice
Our Environmental Stewardship
Bristol-Myers Squibb
Among Greenest
Companies
Ranked 8th among 500
by Newsweek. With nearly all Sustainability 2010 Goals met, we're refocusing on
new horizons.
LATEST NEWS
November 5, 2009
FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients
October 31, 2009
BARACLUDE® (entecavir) Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis
October 31, 2009
Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C
October 29, 2009
Bristol-Myers Squibb Donation to Benefit Students at The Pennington School and Beyond
Bristol-Myers Squibb